Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - mark+segal
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Use of Relaxin as a Therapeutic Agent in Preeclampsia and Other Medical Conditions
Increases the Circulating Number and Activity of Bone Marrow-Derived Endothelial Progenitor Cells Without Causing Inflammation, Offering Potential as a Therapeutic in Cardiovascular DiseaseThis use of the hormone relaxin, relaxin-like peptides or mimetics to positively impact the number and function of bone marrow-derived endothelial progenitor cells...
Published: 6/27/2021
|
Inventor(s):
Mark Segal
,
Kirk Conrad
Keywords(s):
bone marrow derived endothelial cells
,
relaxin
Category(s):
Technology Classifications > Human Health Care
,
Technology Classifications > Human Health Care > Therapeutics